Bioanalysis at Emery Pharma: Your Questions Answered
Are you developing a new drug or biologic and need expert bioanalytical support? In this video, we dive into bioanalysis—what it is, why it’s critical in drug development, and how Emery Pharma supports biotech and pharmaceutical companies across all development phases with cutting-edge instrumentation and GLP-compliant methods.
Topics Covered:
• What is bioanalysis?
• Importance of PK/PD in drug development
• LC-MS/MS, Orbitrap HR-MS, GC-MS, ELISA, and NMR explained
• Method development, validation, and regulatory compliance
• Overcoming bioanalytical challenges
• Emery Pharma’s advanced instrumentation
• Services for small molecules, biologics, peptides, and biomarkers
Bioanalytical Services at Emery Pharma Include:
• LC-MS/MS quantitation of drugs, metabolites, peptides, and biologics
• Orbitrap high-resolution mass spectrometry (HR-MS)
• Triple quadrupole LC-MS/MS (Agilent 6470)
• GC-MS (Thermo ISQ-7000) for volatile/semi-volatile compounds
• Ligand Binding Assays (ELISA) for ADA and biomarker detection
• 400 MHz Multi-Nuclear NMR (GLP/cGMP qualified)
• In vitro ADME, PK, TK studies
Instrumentation Highlights:
• Thermo Orbitrap Exploris 240
• Agilent 6470 Triple Quad LC-MS
• Thermo GC-MS ISQ-7000
• 400 MHz Multi-Nuclear NMR
We Support All Phases of Drug Development:
• Discovery & Preclinical Research
• Clinical Trials (Phases I–III)
• Regulatory Submissions (FDA, EMA, ICH M10 compliant)
Who We Work With:
• Pharmaceutical and biotech companies
• Academic labs and CROs
• Government agencies
Need a Proposal or Have Questions?
Reach out today!
📞 1-888-98-EMERY (36379) or +1 (510) 899-8814
📧 [email protected]
🌐 www.emerypharma.com
Keywords:
bioanalysis, LC-MS/MS, high-resolution mass spectrometry, Orbitrap, GC-MS, NMR, ligand binding assay, ADA detection, PK/PD analysis, method validation, ICH M10, GLP bioanalysis, CRO services, drug development, preclinical studies, clinical trials, bioanalytical lab, pharmaceutical testing, analytical chemistry
Информация по комментариям в разработке